Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine for Injection Related Erythema in RRMS
NCT02568111Phase 4Withdrawn
- Sponsor
- Biogen
- Start
- Feb 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of Onreltea, sponsored by Biogen. Planned start Feb 2016; status: withdrawn.
02
Drugs
Onreltea
Beyond the preview
Go deeper on NCT02568111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568111.